4 matches for your search in the start-up spotlight
rss
CimCure is a 2016 spin-off from Amsterdam UMC. CimCure focuses on the design and development of a novel class of active cancer immunotherapies. The company develops cancer vaccines through its proprietary Immune-Boost (iBoost) technology of targeted conjugate vaccines. They have identified ...
Frame Cancer Therapeutics is a privately funded startup company in the Amsterdam Science Park founded in December 2018. Frame Therapeutics’ goal is to develop its proprietary approach for immunotherapy against cancer, which is based on precise analysis of the DNA and RNA of the tumor of a patient ...
NorthSea is a clinical-stage biopharmaceutical company focused on the development of structurally engineered fatty acids, or SEFAs, for the treatment of metabolic diseases. We are developing SEFAs as a novel class of drugs that are engineered to unlock the therapeutic potential of fatty acids by ...
VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for large disease areas of high unmet medical need. By combining state-of-the-art technologies and novel and scientific concepts, VectorY's mission is to bring innovative ...
